Zobrazeno 1 - 10
of 102
pro vyhledávání: '"John H, Fuller"'
Autor:
Stijn A. Peeters, Lian Engelen, Jacqueline Buijs, Nish Chaturvedi, John H. Fuller, Anders Jorsal, Hans-Henrik Parving, Lise Tarnow, Simone Theilade, Peter Rossing, Casper G. Schalkwijk, Coen D. A. Stehouwer
Publikováno v:
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-9 (2017)
Abstract Background Altered regulation of extracellular matrix (ECM) composition by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) may contribute to arterial stiffening. We investigated associations between circul
Externí odkaz:
https://doaj.org/article/5a41dc8d9920401fac38d3ed4ecdd002
Autor:
Harshal A. Deshmukh, Helen M. Colhoun, Toby Johnson, Paul M. McKeigue, D. John Betteridge, Paul N. Durrington, John H. Fuller, Shona Livingstone, Valentine Charlton-Menys, Andrew Neil, Neil Poulter, Peter Sever, Denis C. Shields, Alice V. Stanton, Aurobindo Chatterjee, Craig Hyde, Roberto A. Calle, David A. DeMicco, Stella Trompet, Iris Postmus, Ian Ford, J. Wouter Jukema, Mark Caulfield, Graham A. Hitman
Publikováno v:
Journal of Lipid Research, Vol 53, Iss 5, Pp 1000-1011 (2012)
We carried out a genome-wide association study (GWAS) of LDL-c response to statin using data from participants in the Collaborative Atorvastatin Diabetes Study (CARDS; n = 1,156), the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT; n = 895), and th
Externí odkaz:
https://doaj.org/article/0e30b62ae4ad49fe9ad70c633f99fac3
Autor:
Coen D.A. Stehouwer, L. Engelen, Lise Tarnow, Simone Theilade, Stijn A. Peeters, John H. Fuller, Casper G. Schalkwijk, Peter Rossing, Nish Chaturvedi, J. Buijs, Hans-Henrik Parving, Anders Jorsal
Publikováno v:
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-9 (2017)
Peeters, S A, Engelen, L, Buijs, J, Chaturvedi, N, Fuller, J H, Jorsal, A, Parving, H-H, Tarnow, L, Theilade, S, Rossing, P, Schalkwijk, C G & Stehouwer, C D A 2017, ' Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes : pooled analysis of three cohort studies ', Cardiovascular Diabetology, vol. 16, 139 . https://doi.org/10.1186/s12933-017-0620-9
Cardiovascular Diabetology, 16:139. BioMed Central Ltd
Cardiovascular Diabetology
Peeters, S A, Engelen, L, Buijs, J, Chaturvedi, N, Fuller, J H, Jorsal, A, Parving, H-H, Tarnow, L, Theilade, S, Rossing, P, Schalkwijk, C G & Stehouwer, C D A 2017, ' Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes : pooled analysis of three cohort studies ', Cardiovascular Diabetology, vol. 16, 139 . https://doi.org/10.1186/s12933-017-0620-9
Cardiovascular Diabetology, 16:139. BioMed Central Ltd
Cardiovascular Diabetology
Background Altered regulation of extracellular matrix (ECM) composition by matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs) may contribute to arterial stiffening. We investigated associations between circulating MMP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::527d3c6bcdadb35dcc128af2586b3fb4
http://link.springer.com/article/10.1186/s12933-017-0620-9
http://link.springer.com/article/10.1186/s12933-017-0620-9
Autor:
Serena Grimaldi, Giuseppe Matullo, Gabriella Gruden, John H. Fuller, Federica Barutta, Graziella Bruno, Nish Chaturvedi, Casper G. Schalkwijk, Coen D.A. Stehouwer
Publikováno v:
Acta Diabetologica, 54(2), 133-139. Springer
Increasing evidence suggests a potential role of circulating miRNAs as clinical biomarkers, and loss of miRNA-126 has been proposed as a predictor of type 2 diabetes onset. However, a systematic analysis of circulating miRNAs in type 1 diabetic patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f4210d4ab6a73de0132798270b9ce6a
https://cris.maastrichtuniversity.nl/en/publications/e514e760-7e3e-4329-92b8-fdb7203f2930
https://cris.maastrichtuniversity.nl/en/publications/e514e760-7e3e-4329-92b8-fdb7203f2930
Autor:
S Balk, Sabita S. Soedamah-Muthu, Danielle A J M Schoenaker, John H. Fuller, Nish Chaturvedi, Gita D. Mishra, M. Toeller
Publikováno v:
European Journal of Clinical Nutrition, 70, 229-236
European Journal of Clinical Nutrition 70 (2016)
European Journal of Clinical Nutrition 70 (2016)
Diet and lifestyle advice for type 1 diabetes (T1DM) patients is based on little evidence and putative effects on glycaemic control. Therefore, we investigated the longitudinal relation between dietary and lifestyle variables and HbA1c levels in pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::395cecd43e0e7661c7cd6dacd845dbbc
https://doi.org/10.1038/ejcn.2015.110
https://doi.org/10.1038/ejcn.2015.110
Autor:
Tahira Akbar, Helen M. Colhoun, D. John Betteridge, Shona Livingstone, Graham A. Hitman, John H. Fuller, H. Andrew W. Neil, Paul N. Durrington, Helen C. Looker
Publikováno v:
Diabetologia
Livingstone, S J, Looker, H C, Akbar, T, Betteridge, D J, Durrington, P N, Hitman, G A, Neil, H A W, Fuller, J H & Colhoun, H M 2016, ' Effect of atorvastatin on glycaemia progression in patients with diabetes : an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS) ', Diabetologia, vol. 59, no. 2, pp. 299-306 . https://doi.org/10.1007/s00125-015-3802-6
Livingstone, S J, Looker, H C, Akbar, T, Betteridge, D J, Durrington, P N, Hitman, G A, Neil, H A W, Fuller, J H & Colhoun, H M 2016, ' Effect of atorvastatin on glycaemia progression in patients with diabetes : an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS) ', Diabetologia, vol. 59, no. 2, pp. 299-306 . https://doi.org/10.1007/s00125-015-3802-6
Aims/hypothesis In an individual-level analysis we examined the effect of atorvastatin on glycaemia progression in type 2 diabetes and whether glycaemia effects reduce the prevention of cardiovascular disease (CVD) with atorvastatin. Methods The stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4552ac9539c23cff40a6f621c10570d3
http://europepmc.org/articles/PMC4705133
http://europepmc.org/articles/PMC4705133
Autor:
Paul N. Durrington, D. John Betteridge, H. Andrew W. Neil, Coen D.A. Stehouwer, Casper G. Schalkwijk, Helen M. Colhoun, David A. DeMicco, Graham A. Hitman, Valentine Charlton-Menys, Shona J. Livingstone, Gregory M. Preston, Weihang Bao, Sabita S. Soedamah-Muthu, John H. Fuller
Publikováno v:
Diabetologia 58 (2015) 7
Diabetologia, 58(7), 1494-1502. Springer, Cham
Diabetologia, 58(7), 1494-1502
Diabetologia
Diabetologia, 58(7), 1494-1502. Springer, Cham
Diabetologia, 58(7), 1494-1502
Diabetologia
Aims/hypothesis We investigated whether atorvastatin 10 mg daily lowered C-reactive protein (CRP) and whether the effects of atorvastatin on cardiovascular disease (CVD) varied by achieved levels of CRP and LDL-cholesterol. Methods CRP levels were me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8bf43819f44c8755dea5c83055996c2
https://doi.org/10.1007/s00125-015-3586-8
https://doi.org/10.1007/s00125-015-3586-8
Autor:
Trevor J. Orchard, Ronald Klein, Dick de Zeeuw, Rudolf W. Bilous, Petra Zürbig, Morten Lindhardt, Peter Rossing, Frederik Persson, Harald Mischak, Hiddo J.L. Heerspink, Angelique Stalmach, Massimo Porta, John H. Fuller, Hans-Henrik Parving, Nish Chaturvedi
Publikováno v:
Nephrology, Dialysis, Transplantation, 32(11), 1866-1873. Oxford University Press
Background: Early prevention of diabetic nephropathy is not successful as early interventions have shown conflicting results, partly because of a lack of early and precise indicators of disease development. Urinary proteomics has shown promise in thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3039c57d3043a4bc1b2fae4e88091c8c
https://research.rug.nl/en/publications/7fabfe79-e9d3-44f2-9b51-c378cdedf6cb
https://research.rug.nl/en/publications/7fabfe79-e9d3-44f2-9b51-c378cdedf6cb
Autor:
Graham A. Hitman, Richard David Leslie, H. Andrew W. Neil, Thomas O. Ola, Chuan Chuan Wun, David A. DeMicco, Paul N. Durrington, D. John Betteridge, Mohammed I. Hawa, Weihang Bao, Ana Paula Buchan, Helen M. Colhoun, John H. Fuller
Publikováno v:
Diabetes Care. 37:1643-1649
OBJECTIVE Diabetes-associated autoantibodies can be detected in adult-onset diabetes, even when initially non–insulin requiring, i.e., with latent autoimmune diabetes. We aimed to identify adult-onset autoimmune diabetes in patients with establishe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bf3a782882c8b53a6d6c0a157c6a2fd
https://doi.org/10.2337/dc13-2383
https://doi.org/10.2337/dc13-2383
Autor:
Sabita S. Soedamah-Muthu, John H. Fuller, Danielle A J M Schoenaker, Nish Chaturvedi, Dominique Simon
Publikováno v:
Journal of Clinical Endocrinology and Metabolism 99 (2014) 3
Journal of Clinical Endocrinology and Metabolism, 99(3), 800-807
Journal of Clinical Endocrinology and Metabolism, 99(3), 800-807
Context: Glycemic targets and the benefit of intensive glucose control are currently under debate because intensive glycemic control has been suggested to have negative effects on mortality risk in type 2 diabetes patients. Objective: We examined the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::531546c577271677b4ad7c6628d97c73
https://doi.org/10.1210/jc.2013-2824
https://doi.org/10.1210/jc.2013-2824